Clinical Trial Update: Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of cannabidiol (CBD) for social anxiety disorder has completed. The update notes the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: EmpowerPharm Inc. | Conditions: Social Anxiety Disorder | Phase 2 | Status: COMPLETED